Cart
sales@molnova.com
TMP-195
CAS No. 1314891-22-9
TMP-195( TMP 195 | TMP195 )
Catalog No. M11271 CAS No. 1314891-22-9
A first-in-class, potent, selective class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) inhibtior with IC50 of 60, 59, 26, and 15 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 106 | In Stock |
|
| 2MG | 64 | In Stock |
|
| 5MG | 106 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | 360 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 622 | In Stock |
|
| 200MG | 885 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTMP-195
-
NoteResearch use only, not for human use.
-
Brief DescriptionA first-in-class, potent, selective class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) inhibtior with IC50 of 60, 59, 26, and 15 nM, respectively.
-
DescriptionA first-in-class, potent, selective class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) inhibtior with IC50 of 60, 59, 26, and 15 nM, respectively; shows no significant inhibition for others HDACs; alters the tumour microenvironment and reduces tumour burden and pulmonary metastases by modulating macrophage phenotypes in mice; induces the recruitment and differentiation of highly phagocytic and stimulatory macrophages within tumours.
-
In Vitro——
-
In Vivo——
-
SynonymsTMP 195 | TMP195
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC4|HDAC5|HDAC7|HDAC9
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1314891-22-9
-
Formula Weight456.42
-
Molecular FormulaC23H19F3N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 82 mg/mL (179.7 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(NCC(C1=COC(C2=CC=CC=C2)=N1)(C)C)C3=CC=CC(C4=NOC(C(F)(F)F)=N4)=C3
-
Chemical NameN-(2-methyl-2-(2-phenyloxazol-4-yl)propyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lobera M, et al. Nat Chem Biol. 2013 May;9(5):319-25.
2. Guerriero JL, et al. Nature. 2017 Mar 16;543(7645):428-432.
3. Cassetta L, et al. Cell Res. 2017 Aug;27(8):963-964.
4. Groselj B, et al. Mol Cancer Ther. 2017 Aug 24. pii: molcanther.0011.2017.
molnova catalog
related products
-
SB-379278A
A potent and selective HDAC8 inhibitor with IC50 of 0.5 uM.
-
NSC 3852
NSC 3852 is a potent inhibitor of histone deacetylase.
-
HDAC8-IN-20a
HDAC8-IN-20a is a potent, selective HDAC8 inhibitor with IC50 of 27 nM.
